And it is liothyronine not Cytomel!
In the research literature drugs are not referred to by brand names. In the context of rigorous attention to scientific data, as opposed to the world of sales and marketing, using trade names would suggest influence by commercial pressures, which would call into question the investigator's independence and objectivity. Shouldn't independence from commercial pressures be just as important in the clinical world? But, surprisingly, in day-to-day practice nobody seems to be at all concerned about this. Everyone — physicians, pharmacists, patients, insurance companies — seems to use brand names to refer to medications. I see this as directly related to the pervasiveness of pharmaceutical company marketing and I believe it is a serious problem. Part of the problem is that no one recognizes it as a problem.
Rest of article at link: